Anzeige
Meldung des Tages: Diese Zahlen lügen nicht: Wie Tiefsee-Knollen den landbasierten Bergbau übertreffen könnten

Inovio Pharma. News

Aktie
WKN:  A400EJ ISIN:  US45773H4092 US-Symbol:  INO Branche:  Biotechnologie Land:  USA
1,20 $
+0,04 $
+3,45%
1,0201 € 17.04.26
Depot/Watchlist
Marktkapitalisierung *
70,23 Mio. €
Streubesitz
61,67%
KGV
-0,75
Index-Zuordnung
-

Inovio Pharmaceuticals News

19.02.26 - PR Newswire
Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact The Gross Law Firm
Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact The Gross Law Firm PR Newswire
18.02.26 - PR Newswire
Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact Levi & Korsinsky
Class Action Filed Against Inovio Pharmaceuticals, Inc. (INO) - April 7, 2026 Deadline to Join - Contact Levi & Korsinsky PR Newswire
17.02.26 - PR Newswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
12.02.26 - PR Newswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO
Pomerantz Law Firm Announces the Filing of a Class Action Against Inovio Pharmaceuticals, Inc. and Certain Officers - INO PR Newswire
12.02.26 - PR Newswire
INOVIO to Participate in Upcoming Scientific and Investor Conferences
INOVIO to Participate in Upcoming Scientific and Investor Conferences PR Newswire
11.02.26 - PR Newswire
INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026
INO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Inovio Pharmaceuticals (INO) Investors of Securities Class Action Deadline on April 7, 2026 PR Newswire
10.02.26 - PR Newswire
IINO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against Inovio Pharmaceuticals, Inc.
IINO Stockholder Alert: Robbins LLP Reminds Investors of the Class Action Against Inovio Pharmaceuticals, Inc. PR Newswire
10.02.26 - PR Newswire
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit PR Newswire
15.01.26 - PR Newswire
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO PR Newswire
08.01.26 - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc. - INO PR Newswire
29.12.25 - PR Newswire
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
FDA Accepts for Review INOVIO's BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP) PR Newswire
19.12.25 - PR Newswire
INOVIO Reports Inducement Grant Under Inducement Plan
INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire
18.11.25 - PR Newswire
INOVIO to Participate in December Investor Conferences
INOVIO to Participate in December Investor Conferences PR Newswire
11.11.25 - PR Newswire
INOVIO Announces Pricing of $25 Million Public Offering
INOVIO Announces Pricing of $25 Million Public Offering PR Newswire
10.11.25 - PR Newswire
INOVIO Announces Proposed Public Offering
INOVIO Announces Proposed Public Offering PR Newswire
10.11.25 - PR Newswire
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights PR Newswire
03.11.25 - PR Newswire
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults PR Newswire
31.10.25 - PR Newswire
INOVIO Reports Inducement Grant Under Inducement Plan
INOVIO Reports Inducement Grant Under Inducement Plan PR Newswire
27.10.25 - PR Newswire
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025 PR Newswire
23.10.25 - PR Newswire
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference PR Newswire

Newssuche

Videos

newspaper
16.04.26 +2,80%
Technical Trading: Treffsichere Signale für Gold
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »